Increased low-density lipoprotein susceptibility to oxidation in pregnancies and fetal growth restriction

Obstetrics and Gynecology

Volumn 106, Issue 2, 2005, Pages 345-351

  Sánchez Vera, Isabel ^a   Bonet, Bartolomé ^a   Viana, Marta ^a   Quintanar, Amalia ^a   López Salva, Antonio ^a  

^a Department of Pediatrics and Neonatology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; CHOLESTEROL; COPPER CHLORIDE; ESTRADIOL; LOW DENSITY LIPOPROTEIN; PLACENTA LACTOGEN; PROGESTERONE;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FETUS; FETUS GROWTH; FETUS WEIGHT; FIRST TRIMESTER PREGNANCY; HORMONE RELEASE; HUMAN; INFARCTION; INTRAUTERINE GROWTH RETARDATION; LIPOPROTEIN METABOLISM; OXIDATION; PLACENTA DISORDER; PLACENTA INFARCTION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 22544453283     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000171112.95083.86     Document Type: Article

References (29)

1. Kliegman RM. Intrauterine growth retardation. In: Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine: diseases of the fetus and infant. 7th ed. St. Louis (MO): Mosby; 2002. p. 228-61.
2. Bakketeig LS, Butte N, de Onis M, Kramer M, O'Donnell A, Prada JA, et al. Report of the IDECG Working Group on definitions, classifications, causes, mechanisms and prevention of IUGR. Eur J Clin Nutr 1998;52 suppl 1:894-6.
3. Binkin NJ, Yip R, Fleshood L, Trowbridge FL. Birth weight and childhood growth. Pediatrics 1988;82:828-34.
4. Lee PA, Kendig JW, Kerrigan JR. Persistent short stature, other potential outcomes, and the effect of growth hormone treatment in children who are born small for gestational age. Pediatrics 2003;112:150-62.
5. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995;38:733-9.
6. Khong TY. Acute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus. Arch Pathol Lab Med 1991;115:722-5.
7. Sheppard BL, Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol 1976;83: 948-59.
8. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6.
9. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157-60.
10. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1997;95:1062-71.
11. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
12. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-27.
13. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
14. Bonet B, Hauge-Gillenwater H, Zhu XD, Knopp RH. LDL oxidation and human placental trophoblast and macrophage cytotoxicity. Proc Soc Exp Biol Med 1998;217:203-11.
15. Bonet B, Chait A, Gown AM, Knopp RH. Metabolism of modified LDL by cultured human placental cells. Atherosclerosis 1995;112:125-36.
16. Delgado Beltrán P, Melchor Marcos JC, Rodríguez-Alarcon Gomez J, Linares Uribe A, Fernández-Llebrez del Rey L, Barbazán Cortés MJ, et al. Curvas de desarrollo fetal de los recién nacidos en el Hospital de Cruces (Vizcaya). An Esp Pediatr 1996;44:50-4.
17. Viana M, Barbas C, Bonet B, Bonet MV, Castro M, Fraile MV, et al. In vitro effects of a flavonoid-rich extract on LDL oxidation. Atherosclerosis 1996; 123:83-91.
18. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
19. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
20. Lavy A, Brook GJ, Dankner G, Amotz AB, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991;40:794-9.
21. Cominacini L, Garbin U, Pastorino AM, Davoli A, Campagnola M, De Santis A et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993;99:63-70.
22. Knopp RH, Zhu XD, Bonet B. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 1994;110 suppl:S83-91.
23. Zhu XD, Bonet B, Knopp RH. 17beta-estradiol, progesterone, and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxicity in cultured placental trophoblast and macrophages. Am J Obstet Gynecol 1997;177:196-209.
24. Sack MN, Rader DJ, Cannon RO 3rd. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
25. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993;341:938-41.
26. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999;354:1234-41.
27. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002;16:1348-60.
28. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-90.
29. Napoli C, Witztum JL, de Nigris F, Palumbo G, D'Armiento FP, Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 1999;99:2003-10.